The present invention relates generally to compounds having melatonin receptor activities and in particular to substituted 2-amidotetralin derivatives; to pharmaceutical preparations comprising such compounds; and to methods for using these compounds as therapeutic and diagnostic reagents.
本发明一般涉及具有
褪黑激素受体活性的化合物,特别是取代的 2-脒基四氢
萘衍
生物;涉及包含这些化合物的药物制剂;以及涉及将这些化合物用作治疗和诊断试剂的方法。